Jonathan Adam Barash is an accomplished Chief Executive Officer with 25 years of global experience as an entrepreneur and executive leader. Throughout his career, he has demonstrated exceptional ability in founding and developing successful businesses, holding pivotal roles including Founder, Director of Marketing, CEO, President, and Board Member across diverse industries such as medical devices,…
A team of researchers led by scientists that has developed fluorescent lateral flow test (FLFT) for our early detection cancer rapid tests. A fluorescent lateral flow test (FLFT) is a diagnostic method that combines traditional lateral flow assay technology with fluorescent labels to enhance sensitivity and quantification. Unlike conventional lateral flow tests that use colloidal…
A distinguished member of a Scientific Advisory Council, which has made significant contributions to cancer immunotherapy, particularly in ovarian cancer. His research focuses on identifying tumor antigens and developing immunotherapeutic strategies, including vaccines and engineered T cells, to enhance the immune system’s ability to combat cancer.
AbulKalam M. Shamsuddin, M.B.,B.S., Ph.D., served as Professor of Pathology at the University of Maryland School of Medicine in Baltimore, MD, for over 43 years, Senior Scientist at National Cancer Institute (NCI), distinguished by numerous awarded U.S. patents. He earned his medical degree from Dhaka Medical College at the University of Dhaka and subsequently completed…